SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (SRIA). The company was selected from a field of ten finalists that included well-established names such as Intuitive, Johnson & Johnson MedTech, Medtronic, and others, according to a press release (https://nnw.fm/mXdgs).
The award recognizes companies based on commercial performance, technological innovation, societal impact, customer recognition, ethical standards, and workplace practices. For investors, this independent industry endorsement highlights SS Innovations' growing presence in the rapidly expanding global surgical robotics market, where healthcare providers are increasingly adopting robotic-assisted procedures across multiple specialties.
Chairman and Chief Executive Officer Dr. Sudhir Srivastava said the award reflects the company's focus on expanding access to robotic surgery while developing technologies aimed at improving affordability for hospitals and healthcare systems. The recognition coincides with continued operational growth for the flagship SSi Mantra surgical robotic platform.
As of June 22, 2026, surgeons had completed 11,719 cumulative multi-specialty procedures using the SSi Mantra system, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric operations. The platform has been used across more than 170 different types of surgical procedures, demonstrating its versatility across multiple disciplines.
Training has also expanded alongside adoption, with approximately 2,100 physicians completing training on the SSi Mantra platform. Physician education and clinical familiarity often influence hospital purchasing decisions and long-term utilization in robotic surgery. The company's commercial footprint continues to broaden internationally, with regulatory approvals granted in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, the Philippines, Sri Lanka, Ukraine, and the United Arab Emirates.
The SSi Mantra is described as a modular, multi-arm robotic surgery platform supporting multiple specialties. It incorporates between three and five robotic arms, a three-dimensional 4K visualization system, an ergonomic surgeon console, and digital imaging capabilities. Its instrument portfolio includes more than 40 robotic surgical instruments, including 5-millimeter instruments for pediatric and ear, nose, and throat procedures. The company has also developed a portable tele-surgeon console, the SSi MantrAsana, supporting remote surgical capabilities, with more than 20 cardiac telesurgeries performed to date.
This award, set against a competitive backdrop, underscores SS Innovations' achievements in expanding access to robotic surgery and its potential for continued growth. For more information, visit the company's website at www.SSInnovations.com. The latest news and updates are available in the company's newsroom at https://nnw.fm/SSII.
